Customer success story
How MedaSystems helped a biotech cut Expanded Access response times from four days to one.
Our partner
A US-based publicly traded biotechnology company currently developing two late-stage, Phase 3-ready therapeutics to treat solid tumors.
The challenge
After the release of positive clinical trial data the company experienced a surge in expanded access requests . The operations team struggled to comply with internal procedures and regulatory requirements using their existing email, PDF forms, and spreadsheet system. The company wanted an end-to-end approach to store all information about each request and a more efficient way to communicate with physicians and their research staff.
The solution
MedaSystems provided an environment for handling requests with care and alacrity. Everyone on the team was able to see exactly where each case stood, what materials and data had been collected, and where the case was in the decision making process. The platform made it easy to see the status of tasks reducing the average time to receive and process requests by approximately 75%.
A confusing process was transformed into a digitized experience with tailored workflows and forms, data is captured in stored in an easily accessible, structured format, and every task is tracked in an easily auditable manner.